Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,864 | 419 | 98.8% |
| Education | $61.49 | 2 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,888 | 160 | $0 (2024) |
| Allergan Inc. | $801.45 | 95 | $0 (2019) |
| Lundbeck LLC | $587.67 | 55 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $449.46 | 37 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $227.88 | 8 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $176.49 | 11 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $151.68 | 11 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $140.15 | 11 | $0 (2024) |
| Axsome Therapeutics, Inc. | $100.64 | 6 | $0 (2024) |
| Neos Therapeutics, LP | $98.72 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,179 | 78 | ABBVIE INC. ($500.14) |
| 2023 | $1,086 | 77 | AbbVie Inc. ($713.40) |
| 2022 | $561.83 | 53 | ABBVIE INC. ($407.74) |
| 2021 | $307.68 | 31 | AbbVie Inc. ($266.60) |
| 2020 | $40.24 | 3 | Lundbeck LLC ($15.39) |
| 2019 | $758.99 | 69 | Allergan Inc. ($235.74) |
| 2018 | $637.30 | 74 | Allergan Inc. ($309.56) |
| 2017 | $355.20 | 36 | Allergan Inc. ($256.15) |
All Payment Transactions
421 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: CNS | ||||||
| 12/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.62 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $8.37 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.19 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.29 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $27.27 | General |
| Category: PSYCHIATRY | ||||||
| 11/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.13 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $11.74 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $9.83 | General |
| Category: PSYCHIATRY | ||||||
| 10/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $6.54 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $22.52 | General |
| Category: ADHD | ||||||
| 10/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: NEUROSCIENCE | ||||||
| 09/23/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.15 | General |
| Category: PSYCHIATRY | ||||||
| 09/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.72 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: PSYCHIATRY | ||||||
| 09/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.77 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $9.08 | General |
| Category: PSYCHIATRY | ||||||
| 08/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.74 | General |
| Category: NEUROSCIENCE | ||||||
| 08/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.19 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: PSYCHIATRY | ||||||
About Dr. Danielle Buda, M.D
Dr. Danielle Buda, M.D is a Psychiatry healthcare provider based in Lincoln, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205944949.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Danielle Buda, M.D has received a total of $4,926 in payments from pharmaceutical and medical device companies, with $1,179 received in 2024. These payments were reported across 421 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($4,864).
Practice Information
- Specialty Psychiatry
- Location Lincoln, NE
- Active Since 08/25/2006
- Last Updated 08/03/2023
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1205944949
Products in Payments
- VRAYLAR (Drug) $2,649
- REXULTI (Drug) $951.26
- CAPLYTA (Drug) $249.21
- INVEGA SUSTENNA (Drug) $227.88
- LATUDA (Drug) $151.68
- TRINTELLIX (Drug) $119.85
- Auvelity (Drug) $100.64
- Adzenys XR-ODT (Drug) $98.72
- Trintellix (Drug) $82.13
- QUVIVIQ (Drug) $50.19
- Horizant (Drug) $42.26
- VIIBRYD (Drug) $39.98
- ABILIFY MAINTENA (Drug) $34.35
- ARISTADA (Drug) $28.51
- HORIZANT (Drug) $18.46
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $18.10
- BRINTELLIX (Drug) $15.39
- APLENZIN (Drug) $13.94
- MYDAYIS (Drug) $11.85
- VYVANSE (Drug) $11.52
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Lincoln
Dr. Walter Duffy, Md, MD
Psychiatry — Payments: $113,922
Dr. James Whalen, M.d, M.D
Psychiatry — Payments: $22,244
Dianna Clyne, M.d, M.D
Psychiatry — Payments: $18,948
Jeffrey Coffman, M.d, M.D
Psychiatry — Payments: $17,744
Kelli Bremer, M.d, M.D
Psychiatry — Payments: $12,411
Dr. Heather Abrahams, Md, MD
Psychiatry — Payments: $8,829